• CDK9 Inhibitor (A3294): Technical Use and Protocol Parameter

  2026-05-20

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for targeted modulation of cyclin dependent kinase 9 activity. It is best suited for research on transcription elongation inhibition and HIV-1 propagation inhibition, but should not be used where broad-spectrum CDK inhibition or extended solution storage is required.

• Machine Learning Accelerates Discovery of Senolytics

  2026-05-20

  This study demonstrates that machine learning models trained on publicly available data can identify potent senolytic compounds, greatly reducing drug screening costs. The approach validated new senolytics with efficacy comparable to known agents, informing the future of targeted interventions in cellular senescence.

• Ibrutinib (PCI-32765): Advanced BTK Inhibition for Precision

  2026-05-19

  Explore how Ibrutinib (PCI-32765) enables unparalleled precision in B-cell receptor signaling inhibition and disease modeling. This article uniquely bridges rigorous pharmacological insight with practical assay guidance, setting a new benchmark for chronic lymphocytic leukemia and autoimmune research.

• TPPU: Potent Soluble Epoxide Hydrolase Inhibitor for Researc

  2026-05-19

  TPPU is a highly potent, selective soluble epoxide hydrolase inhibitor used in inflammatory pain and bone metabolism research. It exhibits nanomolar IC50 values in both human and mouse models, enabling precise modulation of fatty acid epoxide signaling. This compound is widely adopted for preclinical workflows investigating chronic inflammation and redox biology.

• Resolving Pollen Interference in Fluorescence-Based Toxin De

  2026-05-18

  This study presents an advanced workflow combining spectral preprocessing and machine learning to effectively eliminate pollen interference in the fluorescence-based detection of hazardous bioaerosols. The approach significantly improves the accuracy of classifying toxins and pathogens, offering a robust foundation for rapid, real-world bioaerosol monitoring.

• HyperScript™ cDNA Synthesis: Enabling lncRNA Analysis in Can

  2026-05-18

  Explore how the HyperScript First-Strand cDNA Synthesis Kit advances lncRNA research in cancer. This in-depth guide reveals unique technical advantages for low-abundance and structured RNA, and connects them to practical breakthroughs in ovarian cancer biomarker discovery.

• 10074-G5: Advancing c-Myc Inhibitor Research with Mechanisti

  2026-05-17

  Explore the advanced role of 10074-G5 as a c-Myc inhibitor in cancer research. This article offers unique mechanistic insights, protocol guidance, and a practical synthesis of recent MYC/TERT/NFκB axis findings, all grounded in the latest literature.

• Disentangling Drug-Induced Proliferation Arrest and Cell Dea

  2026-05-16

  Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drug responses in vitro, distinguishing cell proliferation arrest from cell death. This approach enables more accurate mechanistic profiling and optimization of preclinical cancer biology assays.

• Halazone: Antimicrobial Sulfonamide Derivative in Lab Workfl

  2026-05-15

  Halazone is a dual-action antimicrobial sulfonamide derivative, excelling in both water disinfection and neuronal sodium channel modulation. Its quantitative efficacy, stability profile, and cross-domain versatility empower reproducible microbiology and neurophysiology experiments.

• ARCA Cy3 EGFP mRNA (5-moUTP): Precision mRNA Imaging & Deliv

  2026-05-15

  ARCA Cy3 EGFP mRNA (5-moUTP) empowers researchers to visualize and quantify mRNA delivery and translation in mammalian cells with exceptional clarity. Its unique combination of Cy3 fluorescence and 5-methoxyuridine modification advances both workflow reproducibility and immune-silent performance, raising the standard for direct-detection and optimization studies.

• Monomethyl Auristatin E (MMAE): Deep Mechanistic Insights an

  2026-05-14

  Explore the mechanistic precision of Monomethyl auristatin E (MMAE) as an antimitotic agent and ADC payload. This article delves into new scientific perspectives and practical assay strategies, setting it apart from existing MMAE content.

• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Guidance

  2026-05-14

  FITC-Concanavalin A (ConA) Conjugate provides a direct, fluorescence-based solution for the detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence and flow cytometry workflows. It should not be used for non-carbohydrate targets, and must be handled strictly within its defined stability and storage conditions to ensure assay reliability.

• Sulfo-NHS-Biotin (SKU A8001): Reliable Cell Surface Labeling

  2026-05-13

  This article addresses recurring challenges in cell viability and protein labeling workflows, illustrating how Sulfo-NHS-Biotin (SKU A8001) offers reproducible and selective solutions for biomedical research. Drawing on laboratory scenarios and recent literature, it provides practical guidance on optimizing use of this water-soluble biotinylation reagent for robust surface protein analysis.

• BIRB 796 (Doramapimod): Precision p38α MAPK Inhibition

  2026-05-13

  BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with a Kd of 0.1 nM, exhibiting robust cytokine inhibition and dual-action mechanism in inflammation research. It demonstrates over 300-fold selectivity versus related kinases and enables targeted modulation of apoptosis and inflammatory pathways.

• Efficient iPSC-to-Retinal Ganglion Cell Differentiation via

  2026-05-12

  This study establishes a robust protocol for differentiating human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) using dual SMAD and Wnt pathway inhibition. The method achieves high purity and reproducibility across iPSC lines, advancing disease modeling and regenerative strategies for glaucoma.

16444 records 1/1097 page Next 12345 下5页 Last page